Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within
individuals, and are designed to be used independently or in conjunction with biomedical treatments. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including major depressive
disorder, schizophrenia, migraine, chronic pain, atopic dermatitis, and more.
For more information, visit ClickTherapeutics.com.
